Aberrant nuclear factor-κB activation is related to the invasiveness and metastasis of renal cell carcinoma

被引：0
|
作者：
Oya, M
Takayanagi, A
Horiguchi, A
Ohtsubo, M
Marumo, K
Shimizu, N
Murai, M
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：124 / 124
页数：1
相关论文
共 50 条
  • [1] Increased nuclear factor-κB activation is related to the tumor development of renal cell carcinoma
    Oya, M
    Takayanagi, A
    Horiguchi, A
    Mizuno, R
    Ohtsubo, M
    Marumo, K
    Shimizu, N
    Murai, M
    [J]. CARCINOGENESIS, 2003, 24 (03) : 377 - 384
  • [2] Osteopontin expression correlates with nuclear factor-κB activation and apoptosis downregulation in clear cell renal cell carcinoma
    Lucin, K.
    Matusan-Ilijas, K.
    Damante, G.
    Fabbro, D.
    Dordevic, G.
    Hadzisejdic, I.
    Grahovac, M.
    Maric, I.
    Spanjol, J.
    Grahovac, B.
    Jonjic, N.
    [J]. VIRCHOWS ARCHIV, 2009, 455 : 146 - 147
  • [3] Osteopontin expression correlates with nuclear factor-κB activation and apoptosis downregulation in clear cell renal cell carcinoma
    Matusan-Ilijas, Koviljka
    Damante, Giuseppe
    Fabbro, Dora
    Dordevic, Gordana
    Hadzisejdic, Ita
    Grahovac, Maja
    Maric, Ivana
    Spanjol, Josip
    Grahovac, Blazenka
    Jonjic, Nives
    Lucin, Ksenija
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2011, 207 (02) : 104 - 110
  • [4] Renal cell carcinoma-derived gangliosides suppress nuclear factor-κB activation in T cells
    Uzzo, RG
    Rayman, P
    Kolenko, V
    Clark, PE
    Cathcart, MK
    Bloom, T
    Novick, AC
    Bukowski, RM
    Hamilton, T
    Finke, JH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (06): : 769 - 776
  • [5] Host nuclear factor-κB activation potentiates lung cancer metastasis
    Stathopoulos, Georgios T.
    Sherrill, Taylor P.
    Han, Wei
    Sadikot, Fluxana T.
    Yull, Fiona E.
    Blackwell, Timothy S.
    Fingleton, Barbara
    [J]. MOLECULAR CANCER RESEARCH, 2008, 6 (03) : 364 - 371
  • [6] Clinicopathological significance of nuclear factor-κB activation in hepatocellular carcinoma
    Yokoo, Hideki
    Yasuda, Jun
    Nakanishi, Kazuaki
    Chuma, Makoto
    Kamiyama, Toshiya
    Todo, Satoru
    Hirohashi, Setsuo
    Sakamoto, Michiie
    [J]. HEPATOLOGY RESEARCH, 2011, 41 (03) : 240 - 249
  • [7] The central role of nuclear factor-κB in mesangial cell activation
    Massy, ZA
    Guijarro, C
    O'Donnell, MP
    Kim, YK
    Kashtan, CE
    Egido, J
    Kasiske, BL
    Keane, WF
    [J]. KIDNEY INTERNATIONAL, 1999, 56 : S76 - S79
  • [8] Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-κB dependent
    An, JB
    Sun, YP
    Fisher, M
    Rettig, MB
    [J]. MOLECULAR CANCER THERAPEUTICS, 2004, 3 (06) : 727 - 736
  • [9] The Prognostic Relevance of Nuclear Factor- B Activation in Papillary Thyroid Carcinoma
    Pyo, J-S
    Kang, G.
    Kim, D-H
    Chae, S. W.
    Sohn, J. H.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 149A - 149A
  • [10] The Prognostic Relevance of Nuclear Factor- B Activation in Papillary Thyroid Carcinoma
    Pyo, J-S
    Kang, G.
    Kim, D-H
    Chae, S. W.
    Sohn, J. H.
    [J]. MODERN PATHOLOGY, 2012, 25 : 149A - 149A
12345